Kangji Medical Holdings Past Earnings Performance

Past criteria checks 3/6

Kangji Medical Holdings has been growing earnings at an average annual rate of 24.9%, while the Medical Equipment industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 17.2% per year. Kangji Medical Holdings's return on equity is 11.5%, and it has net margins of 54.4%.

Key information

24.9%

Earnings growth rate

19.9%

EPS growth rate

Medical Equipment Industry Growth	13.7%
Revenue growth rate	17.2%
Return on equity	11.5%
Net Margin	54.4%
Last Earnings Update	31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Kangji Medical Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SHSC:9997 Revenue, expenses and earnings (CNY Millions)
Date	Revenue	Earnings	G+A Expenses	R&D Expenses
31 Dec 23	926	504	171	128
30 Sep 23	892	540	158	114
30 Jun 23	858	576	145	100
31 Mar 23	822	528	134	83
31 Dec 22	786	479	123	66
30 Sep 22	745	447	122	56
30 Jun 22	704	415	120	46
31 Mar 22	697	436	115	41
31 Dec 21	690	457	109	36
30 Sep 21	654	413	103	33
30 Jun 21	617	369	96	29
31 Mar 21	564	310	95	27
31 Dec 20	511	250	95	25
30 Sep 20	506	227	88	23
30 Jun 20	500	204	81	21
31 Mar 20	502	205	74	19
31 Dec 19	503	206	67	17
31 Dec 18	354	147	43	15
31 Dec 17	248	118	29	10

Quality Earnings: 9997 has high quality earnings.

Growing Profit Margin: 9997's current net profit margins (54.4%) are lower than last year (60.9%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 9997's earnings have grown significantly by 24.9% per year over the past 5 years.

Accelerating Growth: 9997's earnings growth over the past year (5.3%) is below its 5-year average (24.9% per year).

Earnings vs Industry: 9997 earnings growth over the past year (5.3%) exceeded the Medical Equipment industry -10.4%.

Return on Equity

High ROE: 9997's Return on Equity (11.5%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Kangji Medical Holdings Past Earnings Performance

Past criteria checks 3/6

Key information

Recent past performance updates

First half 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.13 in 1H 2022)

Kangji Medical Holdings Limited to Report First Half, 2023 Results on Aug 29, 2023

Full year 2022 earnings released: EPS: CN¥0.40 (vs CN¥0.37 in FY 2021)

First half 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.16 in 1H 2021)

Kangji Medical Holdings Limited to Report First Half, 2022 Results on Aug 25, 2022

Full year 2021 earnings released: EPS: CN¥0.37 (vs CN¥0.26 in FY 2020)

Recent updates

Kangji Medical Holdings Limited Proposes Special Dividend for the Year Ended December 31, 2023

Dividend of CN¥1.40 announced

Kangji Medical Holdings Limited, Annual General Meeting, May 27, 2024

Investor sentiment improves as stock rises 17%

Kangji Medical Holdings Limited Announces CFO Changes

Kangji Medical Holdings Limited Announces the Resignation of Frances Fang Chovanec as Executive Director, Member of Environmental, Social and Governance Committee with Effective from September 15, 2023

First half 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.13 in 1H 2022)

Kangji Medical Holdings Limited to Report First Half, 2023 Results on Aug 29, 2023

Now 21% undervalued after recent price drop

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Kangji Medical Holdings Limited Approves Payment of Final Dividend for the Year Ended December 31, 2022, Payment Date Is 10 July 2023

Full year 2022 earnings released: EPS: CN¥0.40 (vs CN¥0.37 in FY 2021)

Investor sentiment improved over the past week

Less than half of directors are independent

First half 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.16 in 1H 2021)

Kangji Medical Holdings Limited to Report First Half, 2022 Results on Aug 25, 2022

Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2021, Payment date is 08 July 2022

Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2021

Upcoming dividend of HK$0.17 per share

Kangji Medical Holdings Limited Announces Executive Changes

Full year 2021 earnings released: EPS: CN¥0.37 (vs CN¥0.26 in FY 2020)

Less than half of directors are independent

Kangji Medical Holdings Limited to Report Fiscal Year 2021 Results on Mar 22, 2022

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First half 2021 earnings released: EPS CN¥0.16 (vs CN¥0.12 in 1H 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2020

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥0.26 (vs CN¥0.20 in FY 2019)

Kangji Medical Holdings Limited Proposes Final Dividend for the Year Ended December 31, 2020

Investor sentiment improved over the past week

Full year 2020 earnings released

Kangji Medical Holdings Limited to Report Fiscal Year 2020 Results on Mar 25, 2021

New 90-day low: HK$10.88

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

New 90-day low: HK$12.16

Investor sentiment deteriorated over the past week

New 90-day low: HK$14.10

Market pulls back on stock over the past week

Kangji Medical Holdings Limited Appoints Frances Fang Chovanec as Executive Director

First half earnings released

Revenue & Expenses BreakdownBeta

Earnings and Revenue History

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Return on Equity

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Revenue & Expenses Breakdown
Beta